Drug delivery

摘要： The integration of electronics and biology has spawned bioelectronics and opened exciting opportunities to fulfill the unmet needs of therapeutic treatments.Recent developments in nanoelectronics and soft and biocompatible materials have shown potential applicability to clinical practices,including physiological sensing,drug delivery,cardiovascular monitoring,and brain stimulation.To date,most bioelectronic devices require wired connections for electrical control,making their implantation complicated and inconvenient for patients.As an alternative,wireless technology is proliferating to create bioelectronics that offer noninvasive control,biotelemetry,and wireless power transfer(WPT).This review paper provides a comprehensive overview of wireless bioelectronics and ongoing developments in their applications for organ-specific treatments,including disorders and dysfunctions.The main emphasis is on delineating the key features of antennas,namely their radiation characteristics,materials,integration with rest of the electronics,and experimental setup.Although the recent progress in wireless mediated bioelectronics is expected to enhance the control of its functionalities,there are still numerous challenges that need to be addressed for commercialization,as well as to address everexpanding and evolving future therapeutic targets.

摘要： Metal-organic frameworks(MOFs),a crystalline porous material with a periodic net-work structure formed by the self-assembly of transition metal ions and organic ligands,have been widely applied in various fields due to their rich composition and structural diversity.Among vari-ous types of MOFs,stimuli-responsive MOFs have gained increasing attention in recent years,because of their broad application in the field of physics,biology,and chemistry.In this review,we analyzed and classified the mechanism of stimulus-response MOFs(pH response,glucose response,GSH response,light response,temperature response)and their applications in drug delivery,adsorption and luminescence functions,magnetization and catalysis functions,probe and sensor.

摘要： Herbal compounds have enormous potential to enhance the efficacy of current cancer treatments.Several herbal compounds have been reported to enhance the effect of chemotherapy,hormonal therapy and gene therapy on tumor cells.Compared to synthetic formulations,natural products are considered safer and do not have toxic effects at therapeutic doses,thus increasing demand for them.These compounds can significantly effect on signal transduction pathways,reduce side effects,and even inhibit the efflux of anticancer drugs.This review will explain factors influencing herbal nanomedicines,targeting of nanomedicines,nanocarriers used for delivery,herbal nanomedicines in cancer,phytochemical based combinatorial nanomedicines,and challenges to the nanocarriers based cancer therapy.

摘要： Despite the significant progress in cancer therapy,colorectal cancer(CRC)remains one of the most fatal malignancies worldwide.Chemotherapy is currently the mainstay therapeutic modality adopted for CRC treatment.However,the long-term effectiveness of chemotherapeutic drugs has been hampered by their low bioavailability,non-selective tumor targeting mechanisms,non-specific biodistribution associated with low drug concentrations at the tumor site and undesirable side effects.Over the last decade,there has been increasing interest in using nanotechnology-based drug delivery systems to circumvent these limitations.Various nanoparticles have been developed for delivering chemotherapeutic drugs among which polymeric micelles are attractive candidates.Polymeric micelles are biocompatible nanocarriers that can bypass the biological barriers and preferentially accumulate in tumors via the enhanced permeability and retention effect.They can be easily engineered with stimuli-responsive and tumor targeting moieties to further ensure their selective uptake by cancer cells and controlled drug release at the desirable tumor site.They have been shown to effectively improve the pharmacokinetic properties of chemotherapeutic drugs and enhance their safety profile and anticancer efficacy in different types of cancer.Given that combination therapy is the new strategy implemented in cancer therapy,polymeric micelles are suitable for multidrug delivery and allow drugs to act concurrently at the action site to achieve synergistic therapeutic outcomes.They also allow the delivery of anticancer genetic material along with chemotherapy drugs offering a novel approach for CRC therapy.Here,we highlight the properties of polymeric micelles that make them promising drug delivery systems for CRC treatment.We also review their application in CRC chemotherapy and gene therapy as well as in combination cancer chemotherapy.

摘要： Macroencapsulation has been widely used in cell therapy due to its capability to provide immune-privileged sites for implanted allogeneic or xenogeneic cells.Macroencapsulation also serves to provide mechanical and physiochemical support for maintaining cell expansion and promoting therapeutic func-tions.Macroencapsulation devices such as membrane-controlled release systems,hydrogels,micronee-dle(MN)array patches,and three-dimensional(3D)stents have shown promising in-lab and preclinical results in the maintenance of long-term cell survival and the strengthening of treatment effi-cacy.Recent studies focus on expanding the applications of these devices to new cell-based areas such as chimeric antigen receptor(CAR)-T cell delivery,cardiovascular disease therapy,and the exploration of new materials,construction methods,and working principles to augment treatment efficacy and prolong therapy duration.Here,we survey innovative platforms and approaches,as well as translation outcomes,for advancing the performance and applications of macrodevices for cell-based therapies.A discussion and critique regarding future opportunities and challenges is also provided.

摘要： Alzheimer's disease(AD)is an irreversible neurodegenerative disorder,which is pathologically characterized by the deposits of β-amyloid(Aβ),and plays an important role in neuronal death.Indirubin-30-monoxime(I3M)showed neuroprotective effects against Aβ-induced neuronal apoptosis.However,the use of I3M in AD treatment is limited due to its low bioavailability.Herein,PLGA-PEG nanoparticles were synthesized for I3M loading.I3M could release sustainedly sustain release from the I3M-loaded PLGA-PEG nanoparticles(PLGA-PEG-I3M NPs)without obvious burst release.What's more,the PLGA-PEG-I3M NPs could significantly promote the uptake of I3M by PC12 cells through nanoparticle-mediated transport,and improve the efficacy of I3M on the inhibition of Aβfibrillization and oligomerization as well as the neuroprotective activity of I3M on Aβoligomers-induced neuronal death.Thus,the PLGA-PEG-I3M NPs may be a promising platform for AD therapy.

摘要： Micro/nanomaterial-based drug and cell delivery systems play an important role in biomedical fields for their injectability and targeting.Microfluidics is a rapidly developing technology and has become a robust tool for preparing biomaterial micro/nanocarriers with precise structural control and high reproducibility.By flexibly designing microfluidic channels and manipulating fluid behavior,various forms of biomaterial carriers can be fabricated using microfluidics,including microspheres,nanoparticles and microfibers.In this review,recent advances in biomaterials for designing functional microfluidic vehicles are summarized.We introduce the application of natural materials such as polysaccharides and proteins as well as synthetic polymers in the production of microfluidic carriers.How the material properties determine the manufacture of carriers and the type of cargoes to be encapsulated is highlighted.Furthermore,the current limitations of microfluidic biomaterial carriers and perspectives on its future developments are presented.

摘要： Red blood cells(RBCs)are an excellent choice for cell preparation research because of their biocompatibility,high drug loading,and long half-life.In this study,doxorubicin(DOX)was encapsulated with RBCs as the carrier.The biotin-avidin system binding principle was used to modify biotinylated cyclic arginine-glycine-aspartic acid(cRGD)onto RBC surfaces for accurate targeting,high drug loading,and sustained drug release.The RBC drug delivery system(DDS)was characterized,and the concentration of surface sulfur in the energy spectrum was 6.330%.The physical and chemical properties of RBC DDS were as follows:drug content,0.857 mg/mL;particle size,3339 nm;potential value,
12.5 mV;and cumulative release rate,81.35%.There was no significant change in RBC morphology for up to seven days.The results of the targeting and cytotoxicity studies of RBC DDS showed that many RBCs covered the surfaces of U251 cells,and the fluorescence intensity was higher than that of MCF-7 cells.The IC50 value of unmodified drug-loaded RBCs was 2.5 times higher than that of targeted modified drug-loaded RBCs,indicating that the targeting of cancer cells produced satisfactory inhibition.This study confirms that the RBC DDS has the characteristics of accurate targeting,high drug loading,and slow drug release,which increases its likelihood of becoming a clinical cancer treatment in the future.

摘要： Objective: Comparison between semi-ablative and non-ablative radiofrequency for collagen stimulation. Method: Three volunteers with scheduled surgical procedures of abdominoplasty were selected. After the evaluation, the abdominal area was divided into three quadrants, with the right region receiving monopolar non-ablative radiofrequency (RF) application. In contrast, the left region received fractionated radiofrequency (FRF) application, using three different needle sizes (0.5, 1.5, and 3.0 mm), and the intermediate area was kept as a control. After 24 hours, surgery was performed, and the skin flaps were collected for histological and immunohistochemical analyses. Results: An increase in total collagen and type I collagen was observed in the treated groups. There was also an increase in the expression of COX-2, CD68 positive cells (macrophages), and lymphocyte markers (CD3, CD20, and NK-CD57). Furthermore, it was seen that only the use of 3.0-mm needles kept the channels open in the superficial tissue after 24 hours. There were no significant differences between the modalities. Conclusion: Non-ablative and sub-ablative radiofrequency have positive and effective results for flaccidity, demonstrating the success in collagen production. Furthermore, this study is the first to present channel opening and permanence time, which are important to optimize the action of drug delivery.

摘要： Cancer is the second deadliest human disease worldwide with high mortality rate.Rehabilitation and treatment of this disease requires precise and automatic assessment of effective drug response and control system.Prediction of treated and untreated cancerous cell line is one of the most challenging problems for precise and targeted drug delivery and response.A novel approach is proposed for prediction of drug treated and untreated cancer cell line automatically by employing modified Deep neural networks.Human hepatocellular carcinoma(HepG2)cells are exposed to anticancer drug functionalized CFO@BTO nanoparticles developed by our lab.Prediction models are developed by modifying ResNet101 and exploiting the transfer learning concept.Last three layers of ResNet101 are re-trained for the identification of drug treated cancer cells.Transfer learning approach in an appropriate choice especially when there is limited amount of annotated data.The proposed technique is validated on acquired 203 fluorescentmicroscopy images of human HepG2 cells treated with drug functionalized cobalt ferrite@barium titanate(CFO@BTO)magnetoelectric nanoparticles in vitro.The developed approach achieved high prediction with accuracy of 97.5%and sensitivity of 100%and outperformed other approaches.The high performance reveals the effectiveness of the approach.It is scalable and fully automatic prediction approach which can be extended for other similar cell diseases such as lung,brain tumor and breast cancer.